tiprankstipranks
Trending News
More News >
Oric Pharmaceuticals (ORIC)
NASDAQ:ORIC
US Market

Oric Pharmaceuticals (ORIC) Income Statement

Compare
420 Followers

Oric Pharmaceuticals Income Statement

Last quarter (Q3 2025), Oric Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Oric Pharmaceuticals's net income was $-32.59M. See Oric Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -1.11M$ -1.03M$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 141.79M$ 109.75M$ 91.77M$ 78.87M$ 74.19M
Depreciation and Amortization
$ 1.11M$ 1.03M$ 966.00K$ 897.00K$ 970.00K
EBITDA
$ -126.74M$ -109.75M$ -85.80M$ -77.97M$ -48.37M
Operating Income
$ -142.90M$ -110.78M$ -91.77M$ -78.87M$ -74.19M
Other Income/Expenses
$ 15.05M$ 10.08M$ 2.65M$ 156.00K$ 483.00K
Pretax Income
$ -127.85M$ -100.70M$ -89.12M$ -78.72M$ -73.70M
Net Income
$ -127.85M$ -100.70M$ -89.12M$ -78.72M$ -73.70M
Per Share Metrics
Basic EPS
$ -1.83$ -1.96$ -2.25$ -2.07$ -3.36
Diluted EPS
$ -1.83$ -1.96$ -2.25$ -2.07$ -3.36
Weighted Average Shares Outstanding
69.73M 51.45M 39.66M 37.95M 21.94M
Weighted Average Shares Outstanding (Diluted)
69.73M 51.45M 39.66M 37.95M 21.94M
Currency in USD

Oric Pharmaceuticals Earnings and Revenue History